DENT / TRY

DENT / USDT

GPS / USDC

NEWT / USDC

GPS / TRY

NEWT / TRY

GPS / USDT

NEWT / USDT

BIO / USDC

BIO / TRY

EDU / USDT

EDU / TRY

DEGO / USDT

GUN / USDT

GUN / TRY

GUN / BNB

GUN / USDC

DEXE / USDT

BIFI / USDT

RIF / USDT

Z F STEERING GEAR (I) LTD

SHYAM TELECOM LIMITED

MANAKSIA STEELS LTD

ACE INTEGRATED SOLU. LTD.

HAPPY SQUARE OUTSOURC S L

SPECTRUM TALENT MGMT LTD

ROLEX RINGS LIMITED

V.L.INFRAPROJECTS LIMITED

VAISHALI PHARMA LIMITED

MUTHOOT MICROFIN LIMITED

PASHUPATI COTSPIN LIMITED

CRAYONS ADVERTISING LTD

CYBER MEDIA (INDIA) LTD.

GOLDKART JEWELS LIMITED

TAMBOLI INDUSTRIES LTD.

BEACON TRUSTEESHIP LTD

MAYASHEEL VENTURES LTD

QUINT DIGITAL LTD.

SUPREME FACILITY MGMT LTD

SOLARWORLD ENERGY SOL LTD

Click here to get full coverage on Indoco Remedies Q2 net loss narrows to Rs 9 cr - MSN

Indoco Remedies Q2 net loss narrows to Rs 9 cr  MSN

Indoco Remedies Q2 net loss narrows to Rs 9 cr - MSN

Click here to get full coverage on Indoco Remedies Ltd Says U.S. FDA Completed Pre-Approval Inspection At Testing Facility In Chhatrapati Sambaji Nagar - TradingView

Indoco Remedies Ltd Says U.S. FDA Completed Pre-Approval Inspection At Testing Facility In Chhatrapati Sambaji Nagar  TradingView

Indoco Remedies Ltd Says U.S. FDA Completed Pre-Approval Inspection At Testing Facility In Chhatrapati Sambaji Nagar - TradingView

Click here to get full coverage on Five Consecutive Losses Push Indoco Remedies Ltd to a New 52-Week Low - Markets Mojo

Five Consecutive Losses Push Indoco Remedies Ltd to a New 52-Week Low  Markets Mojo

Five Consecutive Losses Push Indoco Remedies Ltd to a New 52-Week Low - Markets Mojo

Click here to get full coverage on Indoco inks pact with UK firm - The Economic Times

Indoco inks pact with UK firm  The Economic Times

Indoco inks pact with UK firm - The Economic Times

Click here to get full coverage on Indoco Remedies (NSE:INDOCO investor three-year losses grow to 42% as the stock sheds ₹2.2b this past week - simplywall.st

Indoco Remedies (NSE:INDOCO investor three-year losses grow to 42% as the stock sheds ₹2.2b this past week  simplywall.st

Indoco Remedies (NSE:INDOCO investor three-year losses grow to 42% as the stock sheds ₹2.2b this past week - simplywall.st

Click here to get full coverage on MCAZ recalls Azithromycin batch over quality concerns - heraldonline.co.zw

MCAZ recalls Azithromycin batch over quality concerns  heraldonline.co.zw

MCAZ recalls Azithromycin batch over quality concerns - heraldonline.co.zw

Click here to get full coverage on Indoco Remedies testing unit clears FDA pre-approval inspection with zero observations - CNBC TV18

Indoco Remedies testing unit clears FDA pre-approval inspection with zero observations  CNBC TV18

Indoco Remedies testing unit clears FDA pre-approval inspection with zero observations - CNBC TV18

Click here to get full coverage on Indoco Remedies Receives USFDA Approval for Lacosamide Oral Solution ANDA - Medical Dialogues

Indoco Remedies Receives USFDA Approval for Lacosamide Oral Solution ANDA  Medical Dialogues

Indoco Remedies Receives USFDA Approval for Lacosamide Oral Solution ANDA - Medical Dialogues

Click here to get full coverage on Indoco Remedies Gains FDA Clearance, Boosts US Market Access - Whalesbook

Indoco Remedies Gains FDA Clearance, Boosts US Market Access  Whalesbook

Indoco Remedies Gains FDA Clearance, Boosts US Market Access - Whalesbook

Click here to get full coverage on Stocks to Watch Today: RailTel, ArisInfra Solutions, Ujjivan Small Finance Bank, Life Insurance Corp, Indoco Remedies, Hindustan Zinc, HG Infra in focus on 15 April- Moneycontrol.com - LinkedIn

Stocks to Watch Today: RailTel, ArisInfra Solutions, Ujjivan Small Finance Bank, Life Insurance Corp, Indoco Remedies, Hindustan Zinc, HG Infra in focus on 15 April- Moneycontrol.com  LinkedIn

Stocks to Watch Today: RailTel, ArisInfra Solutions, Ujjivan Small Finance Bank, Life Insurance Corp, Indoco Remedies, Hindustan Zinc, HG Infra in focus on 15 April- Moneycontrol.com - LinkedIn

Click here to get full coverage on Briefs: Indoco Remedies and Panacea Biotec - Indian Pharma Post

Briefs: Indoco Remedies and Panacea Biotec  Indian Pharma Post

Briefs: Indoco Remedies and Panacea Biotec - Indian Pharma Post

Click here to get full coverage on INDOCO: Exports, APIs, and subsidiaries drove growth; margins improved; Europe and OTC to accelerate - TradingView

INDOCO: Exports, APIs, and subsidiaries drove growth; margins improved; Europe and OTC to accelerate  TradingView

INDOCO: Exports, APIs, and subsidiaries drove growth; margins improved; Europe and OTC to accelerate - TradingView

Click here to get full coverage on Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely - simplywall.st

Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely  simplywall.st

Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely - simplywall.st

Click here to get full coverage on Indoco Remedies Ltd is Rated Strong Sell - Markets Mojo

Indoco Remedies Ltd is Rated Strong Sell  Markets Mojo

Indoco Remedies Ltd is Rated Strong Sell - Markets Mojo

Click here to get full coverage on Indoco Remedies: FDA Ki Clean Chit, Stock **3.86%** Uda! US Market Entry Hui Easy - Whalesbook

Indoco Remedies: FDA Ki Clean Chit, Stock **3.86%** Uda! US Market Entry Hui Easy  Whalesbook

Indoco Remedies: FDA Ki Clean Chit, Stock **3.86%** Uda! US Market Entry Hui Easy - Whalesbook

Click here to get full coverage on MCAZ recalls Indian manufactured antibiotics - MSN

MCAZ recalls Indian manufactured antibiotics  MSN

MCAZ recalls Indian manufactured antibiotics - MSN

Click here to get full coverage on Indoco Remedies shares gain over 8.5% post USFDA approval for Lacosamide oral solution - CNBC TV18

Indoco Remedies shares gain over 8.5% post USFDA approval for Lacosamide oral solution  CNBC TV18

Indoco Remedies shares gain over 8.5% post USFDA approval for Lacosamide oral solution - CNBC TV18

Click here to get full coverage on Indoco Remedies Ltd Opens 9.05% Higher in Sharp Gap Up, But Can the Technicals Support It? - Markets Mojo

Indoco Remedies Ltd Opens 9.05% Higher in Sharp Gap Up, But Can the Technicals Support It?  Markets Mojo

Indoco Remedies Ltd Opens 9.05% Higher in Sharp Gap Up, But Can the Technicals Support It? - Markets Mojo

Click here to get full coverage on Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259 - simplywall.st

Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259  simplywall.st

Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259 - simplywall.st

Click here to get full coverage on Indoco Remedies Gets USFDA Pre-Approval Inspection Cleared At Chhatrapati Sambhaji Nagar - scanx.trade

Indoco Remedies Gets USFDA Pre-Approval Inspection Cleared At Chhatrapati Sambhaji Nagar  scanx.trade

Indoco Remedies Gets USFDA Pre-Approval Inspection Cleared At Chhatrapati Sambhaji Nagar - scanx.trade

Click here to get full coverage on Indoco Remedies Ltd stock jumps after major nod from US Food and Drug Administration—investors rush in - Indiablooms

Indoco Remedies Ltd stock jumps after major nod from US Food and Drug Administration—investors rush in  Indiablooms

Indoco Remedies Ltd stock jumps after major nod from US Food and Drug Administration—investors rush in - Indiablooms

Click here to get full coverage on Stocks to Watch Today: RailTel, ArisInfra Solutions, Ujjivan Small Finance Bank, Life Insurance Corp,... - Moneycontrol.com

Stocks to Watch Today: RailTel, ArisInfra Solutions, Ujjivan Small Finance Bank, Life Insurance Corp,...  Moneycontrol.com

Stocks to Watch Today: RailTel, ArisInfra Solutions, Ujjivan Small Finance Bank, Life Insurance Corp,... - Moneycontrol.com

Click here to get full coverage on Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo

Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals  Markets Mojo

Indoco Remedies Ltd Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo

Click here to get full coverage on Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban - Medical Dialogues

Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban  Medical Dialogues

Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban - Medical Dialogues

Click here to get full coverage on Indoco Remedies jumps 7% post USFDA approval for Brivaracetam oral solution - Business Standard

Indoco Remedies jumps 7% post USFDA approval for Brivaracetam oral solution  Business Standard

Indoco Remedies jumps 7% post USFDA approval for Brivaracetam oral solution - Business Standard

Click here to get full coverage on Pharma stocks trade higher on April 15: Indoco Remedies up 5%, Orchid Pharma gains 4.04%, Dr. Reddy's falls 1.64% - Dailyhunt

Pharma stocks trade higher on April 15: Indoco Remedies up 5%, Orchid Pharma gains 4.04%, Dr. Reddy's falls 1.64%  Dailyhunt

Pharma stocks trade higher on April 15: Indoco Remedies up 5%, Orchid Pharma gains 4.04%, Dr. Reddy's falls 1.64% - Dailyhunt

Click here to get full coverage on Indoco Remedies' testing facility completes US FDA PAI - EquityBulls

Indoco Remedies' testing facility completes US FDA PAI  EquityBulls

Indoco Remedies' testing facility completes US FDA PAI - EquityBulls

Click here to get full coverage on Indoco Remedies gets USFDA nod to sell generic epilepsy medicine - The Economic Times

Indoco Remedies gets USFDA nod to sell generic epilepsy medicine  The Economic Times

Indoco Remedies gets USFDA nod to sell generic epilepsy medicine - The Economic Times

Click here to get full coverage on Indoco Remedies receives USFDA approval for Lacosamide Oral Solution - Business Standard

Indoco Remedies receives USFDA approval for Lacosamide Oral Solution  Business Standard

Indoco Remedies receives USFDA approval for Lacosamide Oral Solution - Business Standard

Click here to get full coverage on Indoco Remedies Receives Final ANDA Approval for Brivaracetam Oral Solution - scanx.trade

Indoco Remedies Receives Final ANDA Approval for Brivaracetam Oral Solution  scanx.trade

Indoco Remedies Receives Final ANDA Approval for Brivaracetam Oral Solution - scanx.trade

Click here to get full coverage on Indoco Remedies rises on USFDA approval for Brivaracetam oral solution - Business Standard

Indoco Remedies rises on USFDA approval for Brivaracetam oral solution  Business Standard

Indoco Remedies rises on USFDA approval for Brivaracetam oral solution - Business Standard

Click here to get full coverage on Indoco Remedies shares gain after Q2 net loss improves, revenue rises 12% - CNBC TV18

Indoco Remedies shares gain after Q2 net loss improves, revenue rises 12%  CNBC TV18

Indoco Remedies shares gain after Q2 net loss improves, revenue rises 12% - CNBC TV18

Click here to get full coverage on Indoco Remedies says Maharashtra GST inspection completed, operations unaffected - CNBC TV18

Indoco Remedies says Maharashtra GST inspection completed, operations unaffected  CNBC TV18

Indoco Remedies says Maharashtra GST inspection completed, operations unaffected - CNBC TV18

Click here to get full coverage on Indoco Remedies shares rise 7% on USFDA approval for Brivaracetam oral solution - CNBC TV18

Indoco Remedies shares rise 7% on USFDA approval for Brivaracetam oral solution  CNBC TV18

Indoco Remedies shares rise 7% on USFDA approval for Brivaracetam oral solution - CNBC TV18

Click here to get full coverage on Indoco Remedies Q3FY26 Results: Revenue Grows 7% to ₹4.34B, Net Loss Widens - scanx.trade

Indoco Remedies Q3FY26 Results: Revenue Grows 7% to ₹4.34B, Net Loss Widens  scanx.trade

Indoco Remedies Q3FY26 Results: Revenue Grows 7% to ₹4.34B, Net Loss Widens - scanx.trade

Click here to get full coverage on Indoco Remedies: Kare Family Trust Completes Substantial Share Acquisition - scanx.trade

Indoco Remedies: Kare Family Trust Completes Substantial Share Acquisition  scanx.trade

Indoco Remedies: Kare Family Trust Completes Substantial Share Acquisition - scanx.trade

Click here to get full coverage on Indoco Remedies Ltd Surges 7.83% to Day's High of Rs 178.7 — Outperforms Sector by 6.23 Percentage Points - Markets Mojo

Indoco Remedies Ltd Surges 7.83% to Day's High of Rs 178.7 — Outperforms Sector by 6.23 Percentage Points  Markets Mojo

Indoco Remedies Ltd Surges 7.83% to Day's High of Rs 178.7 — Outperforms Sector by 6.23 Percentage Points - Markets Mojo

Click here to get full coverage on Indoco Remedies Re-appoints Cost and Internal Auditors for FY2026-27 - scanx.trade

Indoco Remedies Re-appoints Cost and Internal Auditors for FY2026-27  scanx.trade

Indoco Remedies Re-appoints Cost and Internal Auditors for FY2026-27 - scanx.trade

Click here to get full coverage on USFDA successfully completes inspection at Indoco Remedies Mumbai API facility - Medical Dialogues

USFDA successfully completes inspection at Indoco Remedies Mumbai API facility  Medical Dialogues

USFDA successfully completes inspection at Indoco Remedies Mumbai API facility - Medical Dialogues

Click here to get full coverage on Indoco Remedies Q2FY26 Revenue Up, Net Loss at ₹921 Lakh - HDFC Sky

Indoco Remedies Q2FY26 Revenue Up, Net Loss at ₹921 Lakh  HDFC Sky

Indoco Remedies Q2FY26 Revenue Up, Net Loss at ₹921 Lakh - HDFC Sky

Click here to get full coverage on Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg - Express Pharma

Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg  Express Pharma

Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg - Express Pharma

Click here to get full coverage on Indoco Remedies Shares Soar 7% on Securing USFDA Final Approval - Equitypandit

Indoco Remedies Shares Soar 7% on Securing USFDA Final Approval  Equitypandit

Indoco Remedies Shares Soar 7% on Securing USFDA Final Approval - Equitypandit

Click here to get full coverage on Indoco Remedies shares rise 5% on receiving EIR for Patalganga API unit - Business Standard

Indoco Remedies shares rise 5% on receiving EIR for Patalganga API unit  Business Standard

Indoco Remedies shares rise 5% on receiving EIR for Patalganga API unit - Business Standard

Click here to get full coverage on Indoco Remedies Submits Q4 FY26 Compliance Certificate Under SEBI Depositories Regulations - scanx.trade

Indoco Remedies Submits Q4 FY26 Compliance Certificate Under SEBI Depositories Regulations  scanx.trade

Indoco Remedies Submits Q4 FY26 Compliance Certificate Under SEBI Depositories Regulations - scanx.trade

Click here to get full coverage on Indoco Remedies Ltd Opens 5.52% Higher in Sharp Gap Up, But Can the Technicals Support It? - Markets Mojo

Indoco Remedies Ltd Opens 5.52% Higher in Sharp Gap Up, But Can the Technicals Support It?  Markets Mojo

Indoco Remedies Ltd Opens 5.52% Higher in Sharp Gap Up, But Can the Technicals Support It? - Markets Mojo

Click here to get full coverage on Indoco Remedies Q3 Results: Net loss widens, margin expands from last year - CNBC TV18

Indoco Remedies Q3 Results: Net loss widens, margin expands from last year  CNBC TV18

Indoco Remedies Q3 Results: Net loss widens, margin expands from last year - CNBC TV18

Click here to get full coverage on Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.194.4 - Markets Mojo

Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.194.4  Markets Mojo

Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.194.4 - Markets Mojo

Click here to get full coverage on Indoco Remedies gets USFDA EIR for Patalganga facility - Medical Dialogues

Indoco Remedies gets USFDA EIR for Patalganga facility  Medical Dialogues

Indoco Remedies gets USFDA EIR for Patalganga facility - Medical Dialogues

Click here to get full coverage on Indoco Remedies Allots 55,700 Equity Shares Under Employee Stock Option Plan-2022 - scanx.trade

Indoco Remedies Allots 55,700 Equity Shares Under Employee Stock Option Plan-2022  scanx.trade

Indoco Remedies Allots 55,700 Equity Shares Under Employee Stock Option Plan-2022 - scanx.trade

Click here to get full coverage on Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood - Medical Dialogues

Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood  Medical Dialogues

Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood - Medical Dialogues

Click here to get full coverage on Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.189.25 - Markets Mojo

Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.189.25  Markets Mojo

Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.189.25 - Markets Mojo

Click here to get full coverage on Indoco Remedies Gains USFDA Nod for Epilepsy Drug Amidst Profit Concerns - Whalesbook

Indoco Remedies Gains USFDA Nod for Epilepsy Drug Amidst Profit Concerns  Whalesbook

Indoco Remedies Gains USFDA Nod for Epilepsy Drug Amidst Profit Concerns - Whalesbook

Click here to get full coverage on Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.188.9 - Markets Mojo

Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.188.9  Markets Mojo

Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.188.9 - Markets Mojo

Click here to get full coverage on Indoco Remedies Ltd Stock Falls to 52-Week Low Amidst Continued Underperformance - Markets Mojo

Indoco Remedies Ltd Stock Falls to 52-Week Low Amidst Continued Underperformance  Markets Mojo

INDOCO

Price Chart

Key Statistics

Technicals

About INDOCO

Latest News

Indoco Remedies Q2 net loss narrows to Rs 9 cr - MSN

Indoco Remedies Ltd Says U.S. FDA Completed Pre-Approval Inspection At Testing Facility In Chhatrapati Sambaji Nagar - TradingView

Five Consecutive Losses Push Indoco Remedies Ltd to a New 52-Week Low - Markets Mojo

Advanced Charts

Top Gainers

Top Losers